Monday, May 16, 2022

Latest:

Alone at the hands of healthcare: hospital visitor policies during the COVID-19 pandemic
Overactive brain circuit causes anorexia in animal model
Save or splurge: nutrition
Abdominal Wall Hernias and How Telemedicine is Streamlining the Path to Hernia Repair
New insights into the fate of dying cells

Baylor College of Medicine Blog Network

Blog Network
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

cancer immunology

From The Labs

The mTOR pathway: a new avenue for breast cancer cells to promote tumor growth

July 6, 2016anti-tumor response, Cancer, cancer immunology, G-CSF, Immunology, mTOR, myeloid-derived suppressor cells (MDSCs)

Cancer cells respond in various ways to the body’s attempts to eliminate them. One strategy is to recruit immune cells in the body, such as

From the Labs: A closer look at tertiary lymphoid structures. Image courtesy of M. Zelazowski/ P. Castro/Baylor’s Human Tissue Acquisition & Pathology (HTAP) Core.